QA: Bicycle Therapeutics PLC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001761612_2023_Bicycle_Therapeutics_PLC.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}

Graph

Absolute values for 0001761612, Bicycle Therapeutics PLC

  xvar xval
0 AssetsCurrent 369,383,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 19,110,000
3 remainder_Assets 22,116,000
4 LiabilitiesCurrent 53,342,000
5 LiabilitiesNoncurrent 45,029,000
6 remainder_Liabilities 41,455,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 85,241,628
9 ResearchAndDevelopmentExpense 194,762,663
10 remainder_Expenses -1,443,409
11 remainder_Revenues 13,936,104
12 remainder_NetIncome -2,748,174
13 remainder_ComprehensiveNetIncome 7,177,287
  yvar yval
0 Assets 410,609,000
1 Liabilities 139,826,000
2 Expenses 278,560,882
3 Revenues 13,936,104
4 StockholdersEquity 270,783,000
5 NetIncome -267,372,952
6 ComprehensiveNetIncome -263,784,308
7 BaseVar 426,428,724
8 EconomicCapitalRatiobeforeLimitedLiability 1.19
9 EconomicCapitalRatio 2.45

Edgar->Model Mapping

Feature Distribution

Change over Time